Seki cloperastine syrup

Seki is a cough syrup containing cloperastine fendizoate, an antitussive agent that acts centrally and peripherally to suppress coughing without depressing the respiratory center. It is manufactured by Zambon Laboratórios Farmacêuticos Ltda, a pharmaceutical company headquartered in Italy. Zambon specializes in respiratory and central nervous system treatments and has a global presence, with manufacturing facilities in multiple countries. The syrup is available in various markets, including Italy, where it is marketed by Zambon Italia S.r.l. and produced by Zambon S.p.A. in Vicenza. The product is also available in Brazil, where it is marketed by Zambon Laboratórios Farmacêuticos Ltda. The syrup is available in different presentations, including a 200 ml bottle with a measuring cup. The active ingredient, cloperastine fendizoate, is present at a concentration of 3.54 mg/ml, equivalent to 1.8 mg of cloperastine per ml. The syrup is indicated for the treatment of cough and is available over-the-counter in various countries. The product is manufactured in multiple countries, including Italy and Brazil, to meet the demand in different markets. The syrup is available in various presentations, including a 200 ml bottle with a measuring cup. The active ingredient, cloperastine fendizoate, is present at a concentration of 3.54 mg/ml, equivalent to 1.8 mg of cloperastine per ml. The syrup is indicated for the treatment of cough and is available over-the-counter in various countries. The product is manufactured in multiple countries, including Italy and Brazil, to meet the demand in different markets.